Chinese genome sequencing firm BGI, previously know as the Beijing Genomics Institute, has led a RMB200 million (US$30 million) series A funding round in Beijing Gene+ Technology, a gene testing and precision medicine start-up, according to Chinese media reports. Shenzhen-based Green Pine Capital Partners and Shanghai Huoshanshi Capital, a venture firm founded by ex-IDG Capital […]
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.